每一张对照片包含福尔马林固定/石蜡包埋的、未处理和etoposide 处理的Jurkat细胞切片，作为剪切caspase-3 (Asp 175)免疫染色的对照组。可作为以下货号抗体之对照 9664, 9661, 9662, 2035, 9541 Each control slide contains formalin fixed, paraffin-embedded Jurkat cells, both untreated and treated with etoposide, that serve as a control for cleaved caspase-3 (Asp 175) immunostaining. Western blot analysis was performed on extracts derived from the same cells to verify the efficacy of the etoposide treatment. To Be Used With Antibodies 9664, 9661, 9662, 2035, 9541
每一张对照片包含福尔马林固定/石蜡包埋的、 PI3K抑制剂LY294002处理及未处理的LNCaP细胞，它们作为Phospho-Akt (Ser473)免疫染色的对照组。可用于以下货号抗体作对照： 2855, 9644, 4060, 3787, 2938, 4691, 4685, 2920, 9323, 5482,5196, 2997, 2691, 4858, 4857, 2211, 5364, 2217, 2317 Each control slide contains formalin fixed, paraffin-embedded LNCaP cells, both untreated and treated with PI3-Kinase inhibitor LY294002, that serve as a control for Phospho-Akt (Ser473) immunostaining. Western blot analysis was performed on extracts derived from the same cells to verify the efficacy of the LY942002 treatment. To Be Used With Antibodies 2855, 9644, 4060, 3787, 2938, 4691, 4685, 2920, 9323, 5482,5196, 2997, 2691, 4858, 4857, 2211, 5364, 2217, 2317
每一张对照片包含福尔马林固定/石蜡包埋的、经过和未经EGF处理的石蜡包埋的KYSE 450 细胞，以用于磷酸化EGFR免疫组化检测的对照。相关抗体 2235, 2237, 3777, 2236, 2234, 4404, 4407, 4267, 9411, 9417,9416 Each control slide contains formalin fixed, paraffin-embedded KYSE 450 cells, both untreated and treated with EGF, that serve as a control for Phospho-EGFR immunostaining. Western blot analysis was performed on extracts derived from the same cells to verify the efficacy of the EGF treatment. To be used with antibodies: 2235, 2237, 3777, 2236, 2234, 4404, 4407, 4267, 9411, 9417,9416
每一张对照片包含福尔马林固定/石蜡包埋的SK-BR-3细胞，细胞不处理和EGF处理，可以作为免疫染色对照使用。 相关抗体包括 3777, 4407, 4267, 2243, 4290, 2165, 2242, 4791 Each control slide contains formalin-fixed and paraffin-embedded SK-BR-3 cells, untreated and EGF-treated, that can serve as a control for immunostaining. Western blot analysis was performed on extracts derived from the same cells to verify treatment efficacy. To Be Used With Antibodies 3777, 4407, 4267, 2243, 4290, 2165, 2242, 4791
每一张对照片包含福尔马林固定/石蜡包埋的、经过和未经c-Met抑制剂 SU11274处理的，福尔马林固定，石蜡包埋的MKN45 细胞，以用于磷酸化Met (Tyr1234/1235)免疫组化检测的对照。 Each control slide contains formalin fixed, paraffin-embedded MKN45 cells, both untreated and treated with the c-Met inhibitor SU11274, that serve as a control for Phospho-Met (Tyr1234/1235) immunostaining. Western blot analysis was performed on extracts derived from the same cells to verify the efficacy of the SU11274 treatment. To Be Used With Antibody 3077
每一张对照片包含福尔马林固定/石蜡包埋的NIH/3T3细胞，细胞经过U0126 (1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene) #9903或者TPA (12-O-Tetradecanoylphorbol-13-Acetate) #4174处理。这些细胞样本作为phospho-p44/42 MAPK (Thr202/Tyr204)免疫染色的对照。U0126被认为是MEK1、MEK2的高选择性抑制剂。TPA能够诱导p44/42 MAPK的磷酸化。 对应抗体货号：4370, 4376, 4695, 4696, 9102, 9108 Each control slide contains formalin fixed, paraffin-embedded NIH/3T3 cells, treated with either U0126 (1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene) #9903 or TPA (12-O-Tetradecanoylphorbol-13-Acetate) #4174 , that serve as a control for phospho-p44/42 MAPK (Thr202/Tyr204) immunostaining. U0126 has been shown to be a highly selective inhibitor of MEK1 and MEK2. TPA induces phosphorylation of p44/42 MAPK. Western blot analysis was performed on extracts derived from the same cells to verify the efficacy of the U0126 and TPA treatments. To Be Used With Antibodies 4370, 4376, 4695, 4696, 9102, 9108
每一张对照片包含福尔马林固定/石蜡包埋的、 LNCaP 和NIH/3T细胞团。 NIH/3T3细胞表达PTEN而LNCaP 细胞不表达PTEN。相关抗体 9188, 9559 Each control slide contains formalin fixed, paraffin-embedded LNCaP and NIH/3T3 cell pellets. NIH/3T3 cells express PTEN while LNCaP cells do not express PTEN. Western blot analysis was performed on extracts derived from the same cells to verify PTEN expression. To Be Used With Antibodies 9188, 9559
粤公网安备 44010602000434号
